Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP)

Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For... Supplemental Digital Content is available in the text. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Applied Immunohistochemistry & Molecular Morphology Wolters Kluwer Health

Loading next page...
 
/lp/wolters-kluwer-health/fit-for-purpose-pd-l1-biomarker-testing-for-patient-selection-in-qboBxQ9TsL
Publisher
Wolters Kluwer Health
Copyright
Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc
ISSN
1541-2016
DOI
10.1097/PAI.0000000000000800
Publisher site
See Article on Publisher Site

Abstract

Supplemental Digital Content is available in the text.

Journal

Applied Immunohistochemistry & Molecular MorphologyWolters Kluwer Health

Published: Oct 3, 2019

References